Dolutegravir tablet is contraindicated in patients: with previous hypersensitivity reaction to dolutegravir [see Precautions]; receiving dofetilide due to the potential for increased dofetilide plasma concentrations and the risk for serious and/or life-threatening events [see Interactions].